All episodes
Sloan-Kettering Spin-Out Harnesses AI to Diagnose Cancer
Bringing Innovation to Cell and Gene Therapy Manufacturing
Tapping Psychedelics for their Anti-Inflammatory Powers
Advancing Cell Therapies Beyond Cancer
How the Pandemic Transformed a Small Diagnostics Company
Eliminating Security, Privacy, and Regulatory Burdens with Synthetic Data
Using Computational Discovery to Build Better Immunotherapies
The Year in Biotech and What’s Ahead in 2021
Bringing Precision Cancer Care to Dogs
As COVID-19 Vaccines Ship, One Company Brings Innovation to the Vials
Advancing an Antibody to Prevent and Treat Cytokine Storms in COVID-19
Using AI Created Digital Twins to Accelerate Clinical Trials
Modulating RNA to Quell Disease
A Quest to Extend Life through Early Disease Detection
Modulating a Gatekeeper of Cellular Metabolism to Treat a Range of Diseases
Finding the Best Cell for the Job
Transforming Clinical Trials with Digital Technology
Designing Immunotherapies that Can Overcome Recurrence and Resistance
Extending Precision Medicine Beyond Cancer
Growing Biologics
An Experimental COVID-19 Vaccine Begins Human Clinical Trials
Speeding the Delivery of CAR-T Therapies While Cutting the Cost
Transforming Infused Biologics into Injectables
A Novel Approach to NASH That May Have Benefits for COVID 19 As Well
Will a Focus on Protein Dysregulation Help Prothena Break from the Fold
After FDA Set Back, AI Driven Drug Company Advances with New CEO
A Gamified Therapy System Helps People with Brain Injury Recover
Genentech Drug Offers Oral, at-Home Option for SMA Patients
Enabling Precision Medicine through Proteomics
Battling Drug-Resistant Fungal Infections
Making Colorectal Cancer Screening Less of a Pain in the Ass
Targeting Diseases of Aging at a Cellular Level
Cracking the Immune System with AI
Using AI to Improve Drug Companies’ Regulatory Performance
Delivering Biologics Orally
Turning Proteins into Device Coatings that Provide Therapeutic Benefits
Testing if an Approved Antiviral May Prevent COVID-19 Outbreaks
Using AI to Crack COVID-19
Why An Experimental Therapy for Inflammatory Disorders Could Help the Fight Against COVID-19
Modernizing Phage Therapy to Kill Multidrug-Resistant Bacteria
A Rare Disease Drug Hunter Turns His Attention to COVID-19
What It Will Take to Move Beyond the Pandemic
Reading, Writing, and Erasing the Way to Epigenetic Cancer Therapies
Better Immunotherapies Through Chemistry
Bringing the Trial to the Patient
Controlling the Activity of Cell and Gene Therapies with Precision
Why Soon-Shiong Thinks His Triangle Offense for Cancer Can Be Applied to COVID-19
COVID-19, Vaccine Development, and Global Health Lessons from Ebola
Improving Cancer Outcomes with Early Diagnosis
Making A Social Contract That’s Enforceable
Treating Alzheimer’s Disease as an Autoimmune Condition
Fishing for New Drugs
Thoughts on the State of the Antimicrobial Arsenal
A MedTech Company That Thinks Like a Biopharma
Tapping the Potential of Psychedelics to Treat Psychiatric Conditions
Quantifying Neurodegeneration with Precision
Orasis Developing Eye Drops as Alternative to Reading Glasses
Reversing Disease Signals
Turning Cold Tumors Hot
Stabilizing Neuronal Connections to Treat Cognitive Impairment in Alzheimer’s
Our Annual Biotech Review/Preview with STAT’s Adam Feuerstein
An Effort to Eradicate Preventable Blindness
Seeking Success Where Others Have Failed
A New Antibiotic with a Unique Mechanism of Action Hits the Market
Improving Health with Better Data
An Effort to Bioprint a Transplantable Human Heart
How Doctors Are Cracking Difficult Cases with a Social Network
Cala Health Hopes to Win Over Payers and Providers with Its Bioelectric Medicine
Shaping the Emerging Bioeconomy
A Belief that Early Interventions Will Be the Key to Treating Alzheimer’s Disease
Transforming the Study of Microbes with High-Throughput Technology
Using RNA Diagnostics to Predict Patient Response to Immunotherapies
How a Clever Business Model May Accelerate the Use of Companion Diagnostics
Building Cell Therapies with Switches to Modulate Their Activity
Using Synthetic Biology to Build Intelligence into Cell and Gene Therapies
A Therapeutic Approach Built on Protein Degradation
Harnessing AI to Improve Sales and Marketing Decision-Making
A Doctor’s Quest to Cure His Own Rare Disease
Athersys Advances Off-the-Shelf Stem Cell Therapy for Stroke
Enlisting the Innate Immune System to Fight Cancer and other Diseases
Using AI to Improve Clinical Development
Addressing the Challenge of Making Antibody-Drug Conjugates
Targeting Regulators of Genes to Treat Cancer
Harnessing the Immune System to Diagnose and Treat Cancer
Using Synthetic Biology to Produce Cannabinoids
EpicentRx Hopes Rocket-Fuel-Derived Drug Will Propel It
Using Fruit Flies to Personalize Cancer Therapies
Bridging the Gap Between Data and Knowledge with AI
How Virtual Reality May Change the Way Researchers Discover and Develop Drugs
Addressing the Challenges of Drug Development with a New Market
Addressing the Challenge of Producing Stem Cell Therapies with Consistency at Scale
Ensuring a Placebo Response Doesn’t Derail a Clinical Trial
Using AI to Find New Uses for Validated Drugs
Using Digital Health to Change Our Understanding of What Drives Disease
Cidara Advances Antiviral Conjugate to Treat and Prevent Flu
Building a Drug Empire on Undervalued Assets
Bringing Precision Medicine to Autoimmune Disease
Fighting Drug-Resistant Fungal Infections
Accelerating Early-Stage Biotechs
Agenus Advances Broad Immuno-Oncology Pipeline